Welcome to our dedicated page for QT Imaging Holdings news (Ticker: QTIH), a resource for investors and traders seeking the latest updates and insights on QT Imaging Holdings stock.
QT Imaging Holdings (QTIH) delivers innovative medical imaging solutions through advanced diagnostic technology. This news hub provides investors and healthcare professionals with essential updates on the company's developments in non-invasive imaging systems and strategic initiatives.
Access timely press releases covering quarterly earnings, new product approvals, research breakthroughs, and partnership announcements. Our curated collection ensures you stay informed about QTIH's progress in enhancing diagnostic accuracy and expanding clinical applications of its imaging platforms.
Key updates include regulatory milestones, technology licensing agreements, and peer-reviewed study results. Bookmark this page for direct access to original source materials and analysis-free reporting on QTIH's contributions to medical imaging advancements.
QT Imaging Holdings (OTCQB: QTIH) has secured an exclusive distribution agreement with Gulf Medical Co. (GMC) for Saudi Arabia. The agreement covers the distribution of QTI's FDA-cleared Breast Acoustic CT™ scanner and QTI Cloud Platform subscriptions.
The deal mandates minimum orders of 5 scanners per quarter from Q1 2026 through 2028, totaling 60 scanners and generating over $33 million in revenue. The technology is particularly relevant for Saudi Arabia's market, where there's a higher prevalence of BRCA mutations and breast cancer cases among women aged 40-59 years.
The QTI Breast Acoustic CT™ scanner provides non-invasive 3D breast imaging without compression, contrast, or radiation. The company is also developing a QTI Cloud Platform with AI-driven tools for automated findings classification and second-read decision support.
QT Imaging Holdings (OTCQB: QTIH), a medical device company focused on innovative body imaging systems, held its first Annual Stockholder Meeting on August 19, 2025. Stockholders approved three key items: the election of Daniel Dickson and James Greene as Class I directors until 2028, the appointment of BPM LLP as independent auditors for FY2025, and authorization for a reverse stock split with a ratio between 2:1 and 20:1, to be determined by the Board.
QT Imaging Holdings (OTCQB: QTIH) reported strong Q2 2025 financial results, with revenue reaching $3.7 million, representing 113% year-over-year and 31% sequential growth. The company achieved a 50% gross margin and shipped eight QT Breast Acoustic CT™ scanners during Q2, plus two more in July.
Key developments include the launch of the new QTI Cloud Platform, strengthening their transformation into a precision imaging AI company, and amendments to warrant agreements with Lynrock Lake and Yorkville. The company maintains its 2025 revenue guidance of $18 million (40 scanners) and projects $27 million for 2026 (60 scanners).
QT Imaging is pursuing a Nasdaq uplisting and recently raised $700,000 through PIPE investments. The company ended Q2 with $2.0 million in cash, which increased to $4.3 million by August 6, 2025.
[ "Revenue grew 113% year-over-year to $3.7 million in Q2 2025", "Strong gross margin of 50% maintained", "Successfully shipped 8 scanners in Q2 plus 2 more in July 2025", "Cash position improved from $2.0M to $4.3M post-collections", "Secured $700,000 in new PIPE investments", "Operating expenses reduced by 7% year-over-year", "Launch of new QTI Cloud Platform creating potential recurring revenue stream" ]QT Imaging Holdings (OTCQB: QTIH) has launched QTviewer 2.8, an enhanced version of its medical imaging software that complements their FDA-cleared QTI Breast Acoustic CT scanner. The new version introduces significant improvements including stateless DICOM viewing, real-time lesion doubling time analysis, and advanced RGB visualization modes.
The software update features improved multi-series comparison capabilities, optimized viewport layouts, and secure enterprise license management. Notable enhancements include automatic image type recognition and streamlined workflow processes. This release follows the recent introduction of image reconstruction software v4.4.0, which significantly reduced QTscan processing time.
QT Imaging Holdings (OTCQB: QTIH) has announced two key leadership appointments to strengthen its medical and clinical capabilities. Dr. Elaine Iuanow, a board-certified breast radiologist with over 20 years of experience, joins as Chief Medical Officer, while Kim Du becomes Senior Director of Clinical Operations.
The appointments support QTI's expansion of clinical studies and development of AI-driven lesion classification and second-read decision support tools for its FDA-cleared QTI Breast Acoustic CT™ scanner. The technology aims to provide an alternative to MRI, particularly beneficial for the 50% of U.S. women aged 40-74 with dense breast tissue.
The company is focusing on transforming into a precision imaging AI company, with plans to conduct multi-center clinical trials studying their technology as an MRI alternative for high-risk women and breast cancer management.
QT Imaging Holdings (OTCQB: QTIH), a medical device company focused on innovative body imaging systems, has announced its 2025 Annual Meeting of Stockholders. The meeting will be held virtually on August 19, 2025, at 1:00 p.m. EDT.
Stockholders of record as of July 16, 2025 will be eligible to vote at the meeting. Detailed information about the virtual meeting access and participation instructions will be provided in the upcoming proxy statement and made available on the company's investor relations website.
QT Imaging Holdings (OTCQB:QTIH) has released version 4.4.0 of its image reconstruction software for the FDA-cleared QTscan™ Breast Acoustic CT™ scanner. The update, powered by NVIDIA's L40 GPU with Ada Lovelace architecture, significantly reduces image processing time while maintaining diagnostic accuracy and image quality comparable to MRI.
The QTscan™ technology provides non-invasive 3D breast imaging without compression, contrast agents, or ionizing radiation. The software update ensures minimal downtime and seamless workflow integration, enhancing scalability for breast imaging centers with increasing patient volumes. The company continues to develop machine learning algorithms to improve both processing and scanning times.
QT Imaging Holdings (OTCQB:QTIH) has successfully delivered and installed its QT Imaging Breast Acoustic CT™ Scanner at Innovative Radiology in Des Moines, Iowa, marking the first installation of this technology in the state. The scanner utilizes proprietary low-frequency ultrasound technology to create high-resolution, 3D breast images without using ionizing radiation or compression, making it particularly beneficial for patients with dense breast tissue.
Led by Dr. John Tentinger, Innovative Radiology becomes the first facility in Iowa to offer this advanced imaging solution alongside their existing suite of diagnostic technologies, including mammography, MRI, CT, ultrasound, and X-ray. The installation represents a significant step in expanding access to radiation-free breast imaging technology in the region.
QT Imaging Holdings (OTCQB:QTIH), a medical device company focused on body imaging systems, has secured a $200,000 PIPE investment from Mr. Leon Recanati, vice chairman of Israel Cancer Association. The investment terms include the purchase of 205,339 unregistered common stock shares at $0.974 per share, representing a 10% premium to the 5-day VWAP as of May 9, 2025. The deal also includes 205,339 warrants with an exercise price of $1.12 per share.
The transaction, expected to close by May 19, 2025, was placed directly by the company without banking fees. The proceeds will be used as working capital to support business growth.
FAQ
What is the current stock price of QT Imaging Holdings (QTIH)?
What is the market cap of QT Imaging Holdings (QTIH)?
